3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Melanoma
7
Neoplasms
4
Advanced Cancer
4
Lymphoma, Non-Hodgkin
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Lymphoma, Large B-Cell, Diffuse
2
Liver Neoplasms
2
Hodgkin Disease
2
Various Advanced Cancer
1
Uveal Melanoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms by Site
1
Microsatellite Unstable Colorectal Cancer
1
Melanoma, Cutaneous Malignant
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Burkitt Lymphoma
1
Advanced Solid Tumors
1
Interventions
Injections
25
Carboplatin
17
Docetaxel
14
pembrolizumab
12
Paclitaxel
11
Bevacizumab
9
durvalumab
8
Cisplatin
8
Nivolumab
6
Fluorouracil
6
trifluridine tipiracil drug combination
5
tislelizumab
5
linifanib
5
Pemetrexed
5
Oxaliplatin
5
Leucovorin
5
zimberelimab
4
toripalimab
4
talazoparib
4
olaparib
4
Itraconazole
4
Irinotecan
4
Gemcitabine
4
Capecitabine
4
tremelimumab
3
sotorasib
3
sintilimab
3
fludarabine
3
depatuxizumab
3
atezolizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Advanced Solid Tumors
×
relatlimab
×
Clear all
NCT05498480
2024-02-20
RELATIVITY-111
Bristol-Myers Squibb
Phase 1
Completed
6 enrolled